S571-0639 Screening compound: N-{[1-(2-METHOXYETHYL)-2-OXO-1H,2H,3H,4H,4AH,5H,6H-CYCLOPENTA[B]PYRIDIN-4A-YL]METHYL}-5-METHYLPYRAZINE-2-CARBOXAMIDE

S571-0639 Screening compound: N-{[1-(2-METHOXYETHYL)-2-OXO-1H,2H,3H,4H,4AH,5H,6H-CYCLOPENTA[B]PYRIDIN-4A-YL]METHYL}-5-METHYLPYRAZINE-2-CARBOXAMIDE
S571-0639 Screening compound: N-{[1-(2-METHOXYETHYL)-2-OXO-1H,2H,3H,4H,4AH,5H,6H-CYCLOPENTA[B]PYRIDIN-4A-YL]METHYL}-5-METHYLPYRAZINE-2-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound S571-0639
N-{[1-(2-METHOXYETHYL)-2-OXO-1H,2H,3H,4H,4AH,5H,6H-CYCLOPENTA[B]PYRIDIN-4A-YL]METHYL}-5-METHYLPYRAZINE-2-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S571-0639

Molecular Formula

C18H24N4O3 (C18 H24 N4 O3)

Compound Name

N-{[1-(2-METHOXYETHYL)-2-OXO-1H,2H,3H,4H,4AH,5H,6H-CYCLOPENTA[B]PYRIDIN-4A-YL]METHYL}-5-METHYLPYRAZINE-2-CARBOXAMIDE

IUPAC name

n/a

SMILES

Cc(nc1)cnc1C(NCC1(CCC(N2CCOC)=O)C2=CCC1)=O

InChI

InChI=1S/C18H24N4O3/c1-13-10-20-14(11-19-13)17(24)21-12-18-6-3-4-15(18)22(8-9-25-2)16(23)5-7-18/h4,10-11H,3,5-9,12H2,1-2H3,(H,21,24)/t18-/m0/s1

InChI Key

UGRJBQGYGGRXKT-SFHVURJKSA-N

MDL Number (MFCD)

MFCD31961073

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

344.41

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.204

Distribution Coefficient, logD

1.204

Water Solubility, LogSw

-1.84

Polar Surface Area

67.083

Acid Dissociation Constant (pKa)

12.63

Base Dissociation Constant (pKb)

0.23

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

55.60

S571-0639 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
Targets:
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S571-0639 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S571-0639?
Check Price and Availability of S571-0639, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S571-0639 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S571-0639
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S571-0639
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S571-0639 available by request